Manufacturer: Dragon Pharma
Category: Oral Steroids
Substance: Tamoxifen citrate (Nolvadex)
Package: 20mg (100 pills)



NOLVADEX 20 (20 mg / tab, 50 tab) Dragon Pharma is an oral antiestrogen that has been widely used for its intended purpose, both in traditional and sports medicine. In sports practice, it is used either as a testosterone booster (androgen) as part of post-cycle therapy, or as a drug (such as gynecomastia) that eliminates estrogen-dependent side effects directly during the steroid course.

NOLVADEX 20 FROM Dragon Pharma

The basis of the product contains the active ingredient of the same name: tamoxifen is a synthetic antiestrogen developed in the 20th century specifically for medicinal medicinal use. In-in this is approved for administration to a person, since with controlled administration it is characterized by the predominantly beneficial side effect: it is not a steroid, much more toxic or narcotic, which causes consequences, a drug.

NOLVADEX 20 Dragon Pharma belongs to the estrogen receptor blocker group. Its mechanism of action is selective binding to estrogen receptors, a subsequent decrease in estrogen activity and, conversely, an increase in the concentration of androgens. The product actually has no effect on the production of estrogen hormones, but only competes with them for joining receptors.

NOLVADEX 20 Dragon Pharma is an analogue of such drugs as Clomivera, Clomida and Clostilbegit (the active active ingredient is clomiphene), but not identical to Anastrozole and Letrozole (the active ingredients of the same name), also in the first group (clomiphene) is also an estrogen receptor blocker and the latter (anastrozole and letrozole) are aromatase inhibitors.

See info about steroid cycles and PCT protocols

It is important that the reviews on the network NOLVADEX 20 (20mg / tab, 50tab) Dragon Pharma is characterized exclusively positively, because the drug effectively copes with its tasks. Its use is justified with virtually any steroid course, coupled with the risk of inhibition of testosterone synthesis and the manifestation of estrogenic side effects, including gynecomastia in men.

Additional information